Terms ending in 2043
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2043, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 12,702,761 | Lockout Mechanism for Drug Delivery Device In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,128,593 | Manufacturing Process for Hollow Plunger Rod In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,427,241 | Systems and Methods for Drug Delivery In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,723,047 | Heterocyclic Spiro Compounds and Methods of Use In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,552,808 | Diol Desymmetrization by Nucleophilic Aromatic Substitution In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,480,858 | Automated Visual Inspection In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,729,229 | ENGINEERED NRG-1 VARIANTS WITH IMPROVED SELECTIVITY TOWARD ErbB4 BUT NOT AGAINST ErbB3 In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,643,913 | MCL-1 Inhibitor Formulations In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,728,199 | Needle Insertion Mechanism for Drug Delivery Device In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,194,039 | Methods of Treating Heart Failure by Administering Omecamtiv Mecarbil In force · High confidence | Amgen Inc. | In force | High confidence | |
| 43 more term ends in 2043 · Pro | |||||
10 of 53 patents shown. Soonest term end first, then patent number.
Pro members see all 53.
49 of these are in force and held by Amgen Inc..
Updated Nov 20, 2026 · includes USPTO assignment data published Nov 19, 2026, status data published Nov 20, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.